19
Participants
Start Date
July 31, 2011
Primary Completion Date
April 30, 2015
Study Completion Date
April 30, 2015
Leuprolide
Long-acting leuprolide 11.25 mg intramuscularly (IM) pre-transplant (HCT) and 3 months post-HCT PLUS Short-acting leuprolide 0.2 mg subcutaneously (SQ) daily for 14 days
hematopoietic cell transplant
Conventional bone marrow transplant regimen.
reduced intensity allogeneic HCT
A reduced-intensity conditioning transplant is a bone marrow or cord blood transplant (also called a BMT) that uses less intense treatment to prepare for transplant than a standard transplant does. While a standard transplant uses the pre-transplant treatment to destroy most of the disease cells, a reduced-intensity transplant relies on the donor's immune cells to fight disease.
Masonic Cancer Center, University of Minnesota, Minneapolis
Collaborators (1)
Minnesota Medical Foundation
OTHER
Masonic Cancer Center, University of Minnesota
OTHER